Treatment of Conjunctivitis in Patients with Multiple Antibiotic Allergies

Introduction to Treatment

The American Academy of Ophthalmology recommends topical aminoglycosides such as gentamicin as the first-line treatment for bacterial conjunctivitis in patients with allergies to fluoroquinolones, macrolides, trimethoprim, and penicillins 1

For patients with bacterial conjunctivitis, the American Academy of Ophthalmology suggests applying gentamicin ophthalmic solution 1-2 drops every 4 hours for 5-7 days for mild to moderate cases 1
The Centers for Disease Control and Prevention recommend obtaining conjunctival cultures before initiating treatment in moderate to severe cases of bacterial conjunctivitis 1
For gonococcal conjunctivitis, the American Academy of Ophthalmology advises systemic therapy with ceftriaxone (if not allergic to cephalosporins) along with saline lavage 1
The Infectious Diseases Society of America recommends systemic therapy with doxycycline (if not contraindicated) for chlamydial conjunctivitis 1
For MRSA conjunctivitis, the American Academy of Ophthalmology suggests considering vancomycin as topical therapy 2, 3

The American Academy of Ophthalmology recommends first-line treatment including non-pharmacological interventions such as cold compresses 7, refrigerated artificial tears (preservative-free) 7, allergen avoidance 5, and wearing sunglasses as a barrier to airborne allergens 7
The American Academy of Ophthalmology suggests pharmacological options (all topical) including antihistamine/vasoconstrictor combinations (over-the-counter) 5, second-generation topical histamine H1-receptor antagonists 5, mast cell stabilizers for recurrent or persistent cases 7, and dual-action agents (antihistamine + mast cell stabilizer) 7
For inadequate symptom control, the American Academy of Ophthalmology recommends considering a brief course (1-2 weeks) of topical corticosteroids with a low side-effect profile 6, 7

The American Academy of Ophthalmology advises follow-up within 3-4 days if no improvement with initial therapy 1
The American Academy of Ophthalmology recommends monitoring for increased intraocular pressure and cataract formation if using topical corticosteroids 6, 7

The American Academy of Ophthalmology warns against the indiscriminate use of topical antibiotics as they can induce toxicity 4, 5, 6, 7
The American Academy of Ophthalmology cautions that corticosteroids can potentially prolong adenoviral infections and worsen HSV infections 4, 5, 6, 7
The American Academy of Ophthalmology notes that chronic use of vasoconstrictors can lead to rebound vasodilation 4, 5, 6, 7
The American Academy of Ophthalmology advises that oral antihistamines may worsen dry eye syndrome and impair the tear film's protective barrier 6, 7
The Centers for Disease Control and Prevention note that bacterial resistance is a growing concern, particularly with MRSA infections 1